Autoimmune inflammatory myopathy biomarkers

Mickael Essouma
DOI: https://doi.org/10.1016/j.cca.2023.117742
IF: 6.314
2024-01-04
Clinica Chimica Acta
Abstract:The autoimmune inflammatory myopathy disease spectrum, commonly known as myositis, is a group of systemic diseases that mainly affect the muscles, skin and lungs. Biomarker assessment helps in understanding disease mechanisms, allowing for the implementation of precise strategies in the classification, diagnosis, and management of these diseases. This review examines the pathogenic mechanisms and highlights current data on blood and tissue biomarkers of autoimmune inflammatory myopathies.
medical laboratory technology
What problem does this paper attempt to address?